Natural News 6 Nov 2013
In what’s considered one of the country’s largest health care fraud settlements and one of the largest whistleblower payouts in U.S. history, Johnson & Johnson will pay $2.2 billion to settle charges involving the company’s role in marketing three prescription drugs for unapproved uses. As the saying goes, “But wait. There’s more.”
Johnson & Johnson, along with two subsidiaries, Janssen Pharmaceuticals and Scios, also paid kickbacks to doctors and nursing homes who touted their drugs, created “ElderCare Sales Forces” who were paid to push the drug and sent pharmacists to hospitals to assess patient records.
Related articles
- Johnson & Johnson to pay $2 billion for false marketing (money.cnn.com)
- Johnson & Johnson Pays $2 Billion for Misbranding Drugs (on Top of Previous {title}.2 Billion) (fool.com)
- Johnson & Johnson to pay $2.2bn in kickbacks probe (irishexaminer.com)
- Johnson & Johnson to pay $2.2 billion to settle charges of false marketing, kickbacks (boomersurvive-thriveguide.typepad.com)
- Johnson & Johnson fined $2.2 billion for faulty drug claims (abc.net.au)
- Johnson & Johnson Said to Pay $2.2 Billion to End U.S. Marketing Probes (biospace.com)
- Johnson & Johnson To Pay $2.2 Billion To Settle Deceptive Marketing Claims (consumerist.com)
- Johnson & Johnson to pay $2.2 billion to end U.S. probes: source (news.yahoo.com)
- J&J to pay $2.2b in pharma kickback probe – source (nbcnews.com)
- J&J to pay $2.2B to settle marketing allegations (priceofliberty.tumblr.com)
